Information Provided By:
Fly News Breaks for October 9, 2019
Oct 9, 2019 | 07:07 EDT
H.C. Wainwright analyst Swayampakula Ramakanth initiated coverage of Vericel with a Buy rating and $19 price target. In the coming years, the company has the potential to become the standard of care in the $5B cartilage repair market, Ramakanth tells investors in a research note.
News For VCEL From the Last 2 Days
Nov 11, 2019 | 09:48 EST
Meeting to be held in New York on November 12 hosted by BTIG.